You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

2hr plasma glucose

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes Mellitus and Impaired Glucose Regulation

Completed
  • Type 2 Diabetes
  • Impaired Glucose Regulation
  • Plasma transthyretin concentration
  • (no location specified)
May 7, 2022

Diabetes, Type II, Overweight or Obesity Trial (Shake 1 then Shake 2, Shake 2 then Shake 1)

Not yet recruiting
  • Diabetes Mellitus, Type II
  • Overweight or Obesity
  • Shake 1 then Shake 2
  • Shake 2 then Shake 1
  • (no location specified)
Jul 13, 2023

Diabetes, Hypoglycemia, Hyperglycemia Trial in Herlev (Hyperglycemia with slow decline in plasma glucose in type 1 diabetes,

Active, not recruiting
  • Diabetes
  • +4 more
  • Hyperglycemia with slow decline in plasma glucose in type 1 diabetes
  • +8 more
  • Herlev, Denmark
    Steno Diabetes Center Copenhagen
Aug 15, 2022

Healthy Trial in Toronto (Control Cereal (no beta glucan), Cereal with oat beta glucan (OBG), Cereal with barely beta glucan

Not yet recruiting
  • Healthy
  • Control Cereal (no beta glucan)
  • +2 more
  • Toronto, Ontario, Canada
    INQUIS Clinical Research
Sep 26, 2022

Type 1 Diabetes Trial in Montreal (other, device, drug)

Recruiting
  • Type 1 Diabetes
  • Test to induce a decline in plasma glucose
  • +3 more
  • Montreal, Quebec, Canada
    Montreal Clinical Research Institute
Oct 7, 2022

Type 2 Diabetes Trial in Nanjing (Tirzepatide, Insulin Glargine)

Recruiting
  • Type 2 Diabetes Mellitus
  • Nanjing, Jiangsu, China
    Nanjing First Hospital
Sep 21, 2022

Type2 Diabetes Trial in Hellerup (Placebo, GIP receptor antagonization)

Active, not recruiting
  • Type2 Diabetes
  • Placebo
  • GIP receptor antagonization
  • Hellerup, Capital Region, Denmark
    Center for Clinical Metabolic Research, Gentofte Hospital
Sep 16, 2021

Long COVID, Insulin Resistance, Insulin Sensitivity Trial in Palo Alto (Adipose Tissue Biopsy, Steady State Plasma Glucose

Not yet recruiting
  • Long COVID
  • +2 more
  • Adipose Tissue Biopsy
  • Steady State Plasma Glucose (SSPG) Test
  • Palo Alto, California
  • +1 more
Apr 27, 2023

Molecules Associated With Progression of Prediabetes to Overt

Recruiting
  • Type2 Diabetes Mellitus
  • Pre Diabetes
    • London, United Kingdom
      University of Roehampton
    May 17, 2022

    End Stage Renal Disease Trial in Pisa (Empagliflozin, Placebo)

    Completed
    • End Stage Renal Disease
    • Empagliflozin
    • Placebo
    • Pisa, Italy
      Department of Endocrinology and Metabolism, University of Pisa
    Sep 13, 2021

    Type 2 Diabetes Trial in Mersin (Pomegranate Peel)

    Not yet recruiting
    • Type 2 Diabetes
    • Pomegranate Peel
    • Mersin, Yenişehir, Turkey
      Özlem ÖZPAK AKKUŞ
    Feb 8, 2022

    Hyperlipidemias Trial in Toronto (TED + glucose)

    Recruiting
    • Hyperlipidemias
    • TED + glucose
    • Toronto, Ontario, Canada
      Tornto General Hospital, UHN
    Apr 28, 2021

    Diabetes, Type 2 Trial in Tustin (Oral nutrition supplement - control, Oral nutrition supplement - test)

    Completed
    • Diabetes Mellitus, Type 2
    • Oral nutrition supplement - control
    • Oral nutrition supplement - test
    • Tustin, California
      Orange County Research Center
    Aug 16, 2021

    Type 2 Diabetes Trial in China (INSULIN GLARGINE)

    Completed
    • Type 2 Diabetes Mellitus
    • INSULIN GLARGINE
    • Anshan, China
    • +43 more
    Apr 21, 2022

    Food Intakes, Physical Activity, and Psychological Stress on

    Completed
    • Adults
      • Singapore, Singapore
      • +1 more
      Aug 18, 2020

      Assess the Relation Between Glycemic Gab and Adverse Clinical Outcomes in Diabetic Patients Who Hospitalized With Heart Failure

      Not yet recruiting
      • Assess the Relation Between Glycemic Gab and Adverse Clinical Outcomes in Diabetic Patients Who Hospitalized With Heart Failure
      • glycemic gap
      • (no location specified)
      Jun 9, 2021

      Diabetes, Type 2 Trial in Tustin (Balanced Nutritional Drink, Diabetes Specific, Balanced Nutritional Drink (DMA), Diabetes

      Completed
      • Diabetes Mellitus, Type 2
      • Balanced Nutritional Drink
      • +2 more
      • Tustin, California
        Orange County Research Center
      Oct 19, 2021

      Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Los Angeles (procedure, drug, other)

      Not yet recruiting
      • Recurrent Multiple Myeloma
      • Refractory Multiple Myeloma
      • Bone Marrow Aspiration
      • +10 more
      • Los Angeles, California
        Melanie Ayala Ceja
      Jul 10, 2023

      Type 1 Diabetes Trial in Montreal (Physical activity trial intervention)

      Not yet recruiting
      • Type 1 Diabetes
      • Physical activity trial intervention
      • Montreal, Quebec, Canada
        Institut de recherches cliniques de Montréal
      Apr 6, 2023

      Healthy Trial (200mg GCE +200mg ALA, 200mg GCE +400mg ALA, 200mg GCE + 200mg DHB)

      Not yet recruiting
      • Healthy
      • 200mg GCE +200mg ALA
      • +3 more
      • (no location specified)
      Nov 13, 2023

      To Identify Anytime Hyperglycaemia in Normoglycaemia and

      Recruiting
      • Healthy
      • Medtronic G3 sensor
      • New Delhi, Delhi, India
        Fortis CDOC Hospital
      Jul 11, 2023

      Anthocyanins Trial in Davis (ACRB, Placebo)

      Active, not recruiting
      • Anthocyanins
      • ACRB
      • Placebo
      • Davis, California
        UC Davis Nutrition Department
      Dec 20, 2022

      Kuwait Adult Diabetes Epidemiological Multidisciplinary Program

      Recruiting
      • Diabetes Mellitus Type 2, Diabetes Mellitus Type 1
      • +2 more
        • Kuwait City, Kuwait
          Dasman Diabetes Institute
        Oct 30, 2023

        Mitochondrial Dysfunctions Driving Insulin Resistance

        Recruiting
        • Mitochondrial Myopathies
        • +2 more
          • Copenhagen, Denmark
            Rigshospitalet
          Oct 16, 2023

          PreDiabetes, Glucose Tolerance Impaired Trial (APHD-012, APH-012P)

          Not yet recruiting
          • PreDiabetes
          • Glucose Tolerance Impaired
          • (no location specified)
          Apr 5, 2023